SR One

A biotechnology venture capital firm, partnering with founders and entrepreneurs to translate innovative science into medicines.

We are on a mission to power the arc of innovation from science to medicine

SR One takes a back-and-build approach to its investments. Focusing on companies that we believe have strong underlying fundamentals, a clearly defined development pathway, and novel approaches to addressing diseases, SR One aims to help reimagine today’s science for tomorrow’s medicines.

Our transatlantic presence allows us to access high quality science and opportunities across geographies

SR One’s investing team is situated in key biotechnology hubs on the West Coast, USA and London, UK. Our transatlantic footprint positions SR One as a strategic partner for our portfolio companies, providing geographic reach and regional expertise to mine opportunities and lend business support in real time.